Supernus Pharmaceuticals reported $374.79M in Loan Capital for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Adamas Pharmaceuticals ADMS:US 124.48M 1.06M
Aerie Pharmaceuticals AERI:US $ 228.19M 6.17M
Ani Pharmaceuticals ANIP:US $ 186.06M 3.46M
Aphria Inc APH:CN C$ 901.16M 375.72M
Aurora Cannabis Inc ACB:CN 363.25M 4.63M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Canopy Growth Corp WEED:CN C$ 1.52B 120.47M
Corcept Therapeutics CORT:US $ 0M 0M
Eisai 4523:JP Y 49919M 6M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Endo International Ordinary Shares ENDP:US $ 8070.77M 3.67M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Horizon Pharma HZNP:US $ 2557.86M 2.58M
JAZZ PHA JAZZ:US $ 6253.65M 241.68M
Lannett LCI:US $ 596.98M 6.29M
Marinus Pharmaceuticals MRNS:US $ 40.58M 29.61M
Pacira Pharmaceuticals PCRX:US $ 326.15M 4.44M
Perrigo Ordinary Shares PRGO:US $ 2920.9M 4.9M
Revance Therapeutics RVNC:US $ 280.32M 0.32M
Supernus Pharmaceuticals SUPN:US $ 374.79M 4.4M
Teva Pharmaceutical Industries TEVA:US $ 21037M 565M
United Therapeutics UTHR:US $ 800M 0M
Xeris Pharmaceuticals Inc XERS:US $ 87.71M 235K